340B Unscripted

Ep 26 | First Year Anniversary of the 340B Unscripted Podcast - Q & A Session

Aiden shares the 340B questions sent in by our listeners, and there are some good ones. Questions include opening an in-house retail pharmacy, CAR-T therapy, continuum of care and 190 clinics, the IRA, and a couple of other fun ones.
On our one-year anniversary, we want to thank everyone for listening and for all the encouragement we have received.

Ep 25 | 340B Coalition Summer Conference Recap - Part 2

Rob and Greg continue to unpack all the great information gathered from the 2023 340B Coalition Summer Conference in Washington D.C.  They chat with coworkers, clients, and friends in the 340B community to share insights from sessions at the Conference.  Guests include SpendMend colleagues Jennifer Hagen (16:54) and Shakita Carter (38:12), as well as 340B hospital experts Erin Leigh (47:12), Nan Kempadoo (1:00:14) and Pooja Shah (1:14:08). 
 
Submit your questions for Rob and Greg here: https://ww2.spendmend.com/340b-unscripted-qa/

Ep 24 | 340B Coalition Summer Conference Recap

Greg and Rob share highlights from the 340B Coalition Conference in DC. Topics covered include proposed CMS repayment for affected hospitals, Inflation Reduction Act updates, legislative updates, and other worthy conference discussions. 

Ep 23 | 340B and the Medicare Cost Report

Greg and Rob break down the ins and outs of the Medicare Cost Report and the dos and don'ts of child site registrations. They also provide an update on contract pharmacy manufacturer restrictions and information on the upcoming 340B Coalition Conference. We also hear from our Producer Aiden and provide the secret password for your free 340B Unscripted t-shirt at the conference. 

Ep 22 | Maintaining 340B Compliance: Medicaid Duplicate Discount Prevention

In this episode, Greg and Rob talk about an important 340B Program compliance element – preventing Medicaid duplicate discounts.  They discuss the importance of maintaining the Medicaid Exclusion File (MEF), challenges with managing state-specific billing requirements, and strategies for managing out-of-state Medicaid.
In the intro, the guys review updates to manufacturer restrictions for contract pharmacies and share anecdotes from recent HRSA audit experiences. 
 

Ep 21 | Thoughts on 340B & Biosimilar Uptake

In this episode, Greg and Rob discuss a recent publication regarding how 340B Program participation may impact the degree of biosimilar utilization.  Additionally, the guys recap recent legislative proposals with 340B impact that were advanced by the House Energy & Commerce Committee.  
Article citation:  Health Affairs 42, NO. 5 (2023): 632–641 

Ep 20 | 340B History Lesson – The Morford Letter

In this episode, Rob and Greg discuss an interesting piece of 340B history – the Morford letter (25:31).  Rob shares his understanding of the origins of the letter and contemporary application of the letter as it relates to the recent debate around the 340B-eligible patient definition.
But first, the guys catch up on 340B news, including: -A reminder of 340B protections offered under the 2022 Consolidated Appropriations Act (i.e., DSH attestation)-Legislative updates from the House E&C health subcommittee bill mark-up session-Updated manufacturer restrictions for contract pharmacies
 
To access a copy of the Morford Letter: http://content.spendmend.com/assets/Morford-Letter-1.26.01.pdf

Bonus Ep 1 | New 340B Location Qualification and FAQ 4301 Update

Greg and Rob provide a quick update on FAQ 4301 and where we are with HRSA removing language around the immediate use of new 340B locations.